AHR
American Healthcare REIT, Inc.
NYSEUSDEQUITY
Real Estate
DELAYED
Neutral
+5/100
Last price
49.77
▼ 0.72 (1.43%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
50.08
Prev close
50.49
Day high
50.79
Day low
49.50
Volume
831.35K
Market cap
$10.85B
P/E (TTM)
74.28
52W range
40.00 – 58.70
Day trading desk
Gap from prior close
-0.80%
Prior close 50.49
VWAP
49.88
-0.22% from price
Relative volume
0.51×
Quiet session
Session range
2.66%
49.49 – 50.81
Position in range
21%
Near session low
ATR (14D)
0.96
1.94% of price
Prior day high
50.85
PDH
Prior day low
50.02
PDL
Bid / ask spread
—
Quote not published
Session volume
1.46M
Avg 2.88M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.91%
-4.7%
1M
-8.85%
-10.2%
3M
-7.56%
-10.8%
6M
+2.83%
-12.0%
YTD
+5.76%
-8.1%
1Y
+21.39%
+5.8%
3Y
—
-81.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on AHR open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+75.18K
Net buying
Buy transactions
14
108.18K shares
Sell transactions
5
33.00K shares
Net transactions
+19
Buys less sells
Sell : buy shares
0.3 : 1
Mixed
Insider-held shares
1.32M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 25, 26 | FOSTER MARK E. Officer |
SELL | 1.50K | $78.09K | Direct |
| Sep 1, 26 | FOSTER MARK E. General Counsel |
SELL | 2.00K | $110.78K | Direct |
| Jul 21, 26 | PROSKY DANNY Director |
— | 51.80K | — | Direct |
| Jul 21, 26 | PROSKY DANNY Director |
STOCK | 2.59K | $0 | Direct |
| Jun 26, 26 | PEAY BRIAN SCOTT Chief Financial Officer |
SELL | 25.00K | $1.27M | Direct |
| Jun 24, 26 | FOSTER MARK E. General Counsel |
SELL | 2.50K | $121.45K | Direct |
| Jun 24, 26 | ESTES SCOTT A Director |
STOCK | 2.59K | $0 | Direct |
| Jun 24, 26 | STREIFF MATHIEU B Director |
STOCK | 2.59K | $0 | Direct |
| Jun 24, 26 | O'QUINN MARVIN R Director |
STOCK | 2.59K | $0 | Direct |
| Jun 24, 26 | HURLEY DIANNE Director |
STOCK | 2.59K | $0 | Direct |
| Jun 24, 26 | RICHARDSON VALERIE Director |
STOCK | 2.59K | $0 | Direct |
| Jun 24, 26 | FLORNES BRIAN J Director |
STOCK | 2.59K | $0 | Direct |
| Jun 24, 26 | SMITH WILBUR H. III Director |
STOCK | 2.59K | $0 | Direct |
| Jun 1, 26 | FOSTER MARK E. General Counsel |
SELL | 2.00K | $96.64K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
FLORNES BRIAN J |
Director | 33.02K | Stock Award(Grant) |
FOSTER MARK E. |
Officer | 50.12K | Sale |
HANSON JEFFREY T. |
Director | — | Sale |
HURLEY DIANNE |
Director | 34.04K | Stock Award(Grant) |
OH STEFAN K.L. |
Chief Investment Officer | 96.99K | Conversion of Exercise of derivative security |
PEAY BRIAN SCOTT |
Chief Financial Officer | 153.51K | Sale |
PROSKY DANNY |
Director | 515.00K | Conversion of Exercise of derivative security |
SMITH WILBUR H. III |
Director | 35.01K | Stock Award(Grant) |
STREIFF MATHIEU B |
Director | 192.37K | Stock Award(Grant) |
WILLHITE GABRIEL M. |
Chief Operating Officer | 148.16K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$10.85B
Enterprise value$12.46B
Revenue (TTM)$2.50B
Gross profit$482.94M
EBITDA$447.40M
Net income$121.02M
EPS (TTM)$0.67
Free cash flow$396.68M
Total cash$157.85M
Total debt$1.57B
Book value / share$18.98
Shares outstanding218.00M
Float216.56M
Short % of float12.96%
Dividend yield1.98%
Beta (5Y)0.80
Valuation & profitability ratios
Trailing P/E74.28
Forward P/E50.27
PEG ratio—
Price / sales—
Price / book2.62
EV / revenue4.98
EV / EBITDA27.86
Gross margin19.28%
Operating margin6.83%
Profit margin4.83%
Return on equity3.95%
Return on assets2.10%
Debt / equity41.89
Current ratio1.31
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.26B | $2.07B | $1.86B | $1.62B | +9.1% |
| Operating revenue | $2.26B | $2.07B | $1.86B | $1.62B | +9.1% |
| Cost of revenue | $1.79B | $1.65B | $1.50B | $1.28B | +8.4% |
| Gross profit | $466.59M | $416.77M | $356.83M | $335.97M | +12.0% |
| Selling, general & admin | $110.17M | $100.80M | $104.98M | $103.10M | +9.3% |
| Total operating expense | $297.73M | $279.99M | $280.11M | $245.38M | +6.3% |
| Operating income | $168.87M | $136.78M | $76.72M | $90.59M | +23.5% |
| Net interest income | -$85.78M | -$127.73M | -$163.19M | -$105.96M | +32.8% |
| Pre-tax income | $48.65M | -$33.89M | -$76.22M | -$72.80M | +243.6% |
| Tax provision | -$22.17M | $1.71M | $663.00K | $586.00K | -1,394.3% |
| Net income | $69.81M | -$37.81M | -$71.47M | -$81.30M | +284.6% |
| Net income to common | $69.81M | -$37.81M | -$71.47M | -$81.30M | +284.6% |
| Basic EPS | 0.42 | -0.29 | -1.08 | -1.23 | +244.8% |
| Diluted EPS | 0.42 | -0.29 | -1.08 | -1.23 | +244.8% |
| EBIT | $134.42M | $93.84M | $86.97M | $33.16M | +43.2% |
| EBITDA | $359.62M | $315.48M | $324.26M | $233.76M | +14.0% |
| Basic shares | 166.06M | 130.64M | 66.05M | 66.21M | +27.1% |
| Diluted shares | 166.85M | 130.64M | 66.05M | 66.21M | +27.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $114.84M | $76.70M | $43.45M | $65.05M | +49.7% |
| Cash & short-term investments | $114.84M | $76.70M | $43.45M | $65.05M | +49.7% |
| Accounts receivable | $204.31M | $211.10M | $185.38M | $137.50M | -3.2% |
| Inventory | $18.84M | $19.48M | $19.47M | $19.77M | -3.3% |
| Total current assets | $374.90M | $354.89M | $297.10M | $269.18M | +5.6% |
| Property, plant & equipment | $135.40M | $163.99M | $227.85M | $276.34M | -17.4% |
| Goodwill & intangibles | $488.18M | $396.42M | $415.41M | $467.89M | +23.1% |
| Total assets | $5.43B | $4.49B | $4.58B | $4.79B | +20.9% |
| Total current liabilities | $867.50M | $946.86M | $1.47B | $1.53B | -8.4% |
| Current debt | $549.76M | $688.53M | $1.22B | $1.28B | -20.2% |
| Long-term debt | $1.00B | $1.02B | $1.34B | $1.28B | -1.6% |
| Total debt | $1.69B | $1.87B | $2.79B | $2.83B | -9.9% |
| Total liabilities | $2.07B | $2.18B | $3.12B | $3.14B | -5.4% |
| Retained earnings | -$1.56B | -$1.46B | -$1.28B | -$1.14B | -6.9% |
| Shareholder equity | $3.32B | $2.26B | $1.27B | $1.40B | +46.9% |
| Working capital | -$492.60M | -$591.96M | -$1.17B | -$1.26B | +16.8% |
| Net tangible assets | $2.83B | $1.86B | $854.91M | $932.20M | +51.9% |
| Shares issued | 185.91M | 157.45M | 66.23M | 66.21M | +18.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $70.82M | -$35.60M | -$76.89M | -$73.38M | +298.9% |
| Depreciation & amortisation | $225.20M | $221.64M | $237.30M | $200.60M | +1.6% |
| Stock-based compensation | $14.62M | $9.87M | $5.47M | $3.91M | +48.1% |
| Change in working capital | -$30.32M | -$68.68M | -$55.79M | -$37.80M | +55.9% |
| Operating cash flow | $294.44M | $176.09M | $98.53M | $147.77M | +67.2% |
| Capital expenditure | -$128.56M | -$91.94M | -$99.79M | -$71.52M | -39.8% |
| Investing cash flow | -$1.08B | -$8.73M | $9.40M | -$118.58M | -12,303.2% |
| Share buybacks | $0 | -$14.00K | -$469.00K | -$20.70M | +100.0% |
| Dividends paid | -$163.52M | -$120.89M | -$76.28M | -$51.12M | -35.3% |
| Financing cash flow | $817.24M | -$134.74M | -$129.06M | -$42.92M | +706.5% |
| Free cash flow | $165.88M | $84.15M | -$1.26M | $76.25M | +97.1% |
| End cash position | $151.75M | $123.30M | $90.78M | $111.91M | +23.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $674.25M | $650.77M | $604.08M | $572.94M | $542.50M | +3.6% |
| Operating revenue | $674.25M | $650.77M | $604.08M | $572.94M | $542.50M | +3.6% |
| Cost of revenue | $524.84M | $512.17M | $480.29M | $454.53M | $426.29M | +2.5% |
| Gross profit | $149.41M | $138.60M | $123.79M | $118.41M | $116.22M | +7.8% |
| Selling, general & admin | $32.06M | $30.70M | $28.74M | $26.70M | $27.93M | +4.4% |
| Total operating expense | $104.19M | $97.77M | $84.06M | $75.88M | $69.87M | +6.6% |
| Operating income | $45.22M | $40.84M | $39.73M | $42.53M | $46.34M | +10.7% |
| Net interest income | -$18.63M | -$18.80M | -$19.81M | -$20.39M | -$22.63M | +0.9% |
| Pre-tax income | $30.98M | $23.49M | $8.53M | $35.55M | $10.81M | +31.9% |
| Tax provision | -$3.00K | -$525.00K | -$2.42M | -$21.09M | $732.00K | +99.4% |
| Net income | $30.61M | $23.71M | $10.78M | $55.93M | $9.91M | +29.1% |
| Net income to common | $30.61M | $23.71M | $10.78M | $55.93M | $9.91M | +29.1% |
| Basic EPS | 0.16 | 0.13 | 0.06 | 0.33 | 0.06 | +23.1% |
| Diluted EPS | 0.16 | 0.13 | 0.06 | 0.33 | 0.06 | +23.1% |
| EBIT | $49.60M | $42.28M | $28.33M | $55.94M | $33.44M | +17.3% |
| EBITDA | $130.76M | $118.27M | $92.54M | $114.66M | $84.78M | +10.6% |
| Basic shares | 192.71M | 187.32M | 177.53M | 169.01M | 160.50M | +2.9% |
| Diluted shares | 193.35M | 187.97M | 178.39M | 169.80M | 161.14M | +2.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $156.90M | $119.38M | $114.84M | $147.36M | $133.49M | +31.4% |
| Cash & short-term investments | $156.90M | $119.38M | $114.84M | $147.36M | $133.49M | +31.4% |
| Accounts receivable | $229.63M | $241.59M | $204.31M | $188.60M | $224.07M | -5.0% |
| Inventory | $20.51M | $20.44M | $18.84M | $20.24M | $19.43M | +0.3% |
| Total current assets | $442.72M | $419.52M | $374.90M | $393.38M | $414.01M | +5.5% |
| Property, plant & equipment | $124.38M | $130.41M | $135.40M | $140.70M | $147.89M | -4.6% |
| Goodwill & intangibles | $472.18M | $485.37M | $488.18M | $416.31M | $390.83M | -2.7% |
| Total assets | $5.70B | $5.60B | $5.43B | $4.77B | $4.51B | +1.9% |
| Total current liabilities | $882.02M | $890.08M | $867.50M | $847.75M | $823.33M | -0.9% |
| Current debt | $549.87M | $549.82M | $549.76M | $549.70M | $549.63M | +0.0% |
| Long-term debt | $892.68M | $996.05M | $1.00B | $1.01B | $1.02B | -10.4% |
| Total debt | $1.57B | $1.68B | $1.69B | $1.70B | $1.72B | -6.5% |
| Total liabilities | $1.96B | $2.08B | $2.07B | $2.05B | $2.04B | -5.5% |
| Retained earnings | -$1.60B | -$1.58B | -$1.56B | -$1.52B | -$1.54B | -1.2% |
| Shareholder equity | $3.69B | $3.48B | $3.32B | $2.68B | $2.42B | +6.1% |
| Working capital | -$439.30M | -$470.57M | -$492.60M | -$454.37M | -$409.32M | +6.6% |
| Net tangible assets | $3.22B | $3.00B | $2.83B | $2.26B | $2.03B | +7.5% |
| Shares issued | 194.69M | 189.94M | 185.91M | 171.03M | 164.58M | +2.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $30.98M | $24.01M | $10.94M | $56.64M | $10.08M | — | +29.0% |
| Depreciation & amortisation | $81.16M | $75.99M | $64.21M | $58.72M | $51.34M | — | +6.8% |
| Stock-based compensation | $5.77M | $4.86M | $5.45M | $3.43M | $3.19M | — | +18.7% |
| Change in working capital | $6.56M | -$21.20M | -$34.92M | $21.65M | -$8.09M | — | +131.0% |
| Operating cash flow | $118.62M | $81.07M | $55.16M | $107.19M | $71.47M | — | +46.3% |
| Capital expenditure | -$47.69M | -$38.32M | -$48.13M | -$32.35M | -$26.90M | — | -24.5% |
| Investing cash flow | -$173.34M | -$203.09M | -$709.97M | -$278.46M | -$62.09M | — | +14.6% |
| Share buybacks | — | — | $0 | $0 | $0 | $0 | — |
| Dividends paid | -$47.61M | -$46.82M | -$42.86M | -$41.24M | -$39.88M | — | -1.7% |
| Financing cash flow | $89.46M | $127.20M | $622.20M | $185.69M | $33.12M | — | -29.7% |
| Free cash flow | $70.93M | $42.75M | $7.03M | $74.83M | $44.58M | — | +65.9% |
| End cash position | $191.62M | $156.88M | $151.75M | $184.36M | $169.99M | — | +22.1% |
Options analytics
Put / call volume
5.08
Put-heavy session
Put / call open interest
0.53
Positioning, not flow
Max pain
50.00
+0.5% from spot
ATM implied vol
36.8%
Nearest strike to spot
Skew (10% OTM)
+26.3%
Puts bid over calls
Call volume
40
Contracts, this expiry
Put volume
203
Contracts, this expiry
Heaviest call OI
55.00
381 contracts
Heaviest put OI
45.00
215 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.14 | 0.15 | +11.5% |
| Mar 2026 | 0.15 | 0.14 | -7.4% |
| Dec 2025 | 0.15 | 0.14 | -6.3% |
| Sep 2025 | 0.15 | 0.27 | +74.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.16 | 1 | $715.63M | +24.9% |
| Next quarter | 0.20 | 1 | $749.84M | +24.1% |
| Current year | 0.61 | 6 | $2.78B | +22.9% |
| Next year | 0.99 | 1 | $3.19B | +14.7% |
Analyst targets & ownership
Mean target$64.40
High target$74.00
Low target$55.00
Implied upside29.40%
Analyst count15
ConsensusSTRONG BUY
Strong buy / Buy6 / 9
Hold0
Sell / Strong sell0 / 0
Held by insiders0.61%
Held by institutions99.32%
Institutions holding770
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
51.17
-2.74% from price
SMA 20
52.00
-4.29% from price
SMA 50
53.99
-7.81% from price
SMA 100
52.63
-5.44% from price
SMA 200
51.05
-2.52% from price
EMA 12
51.22
-2.84% from price
EMA 26
52.33
-4.89% from price
EMA 50
53.00
-6.10% from price
RSI (14)
26.2
Oversold
MACD (12,26,9)
-1.10
Hist -0.16
ATR (14)
0.96
1.94% of price
Realised vol 30D
14.7%
Annualised
Bollinger upper
54.30
20, 2σ
Bollinger lower
49.70
20, 2σ
50 / 200 cross
Golden
53.99 vs 51.05
Trend bias
Below 200
-2.52%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.02
Less volatile than market
Correlation to SPY
0.01
Largely independent
Realised vol 30D
14.7%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-14.1%
Peak to trough
Max drawdown 5Y
-14.1%
Peak to trough
ATR 14
0.96
1.94% of price
Beta (reported)
0.80
5Y monthly, from filing
Short interest
Shares short
24.87M
Prior 29.50M
Change vs prior
-15.7%
Shorts covering
% of float
12.96%
Elevated
% of shares out
11.41%
Against total outstanding
Days to cover
9.7
Crowded exit
Float
216.56M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 2, 26 | Scotiabank | MAINTAINED | Sector Outperform | Sector Outperform |
| Aug 31, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Aug 19, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Aug 14, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Aug 14, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Aug 13, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Jul 27, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Jul 21, 26 | Compass Point | INITIATED | — | Buy |
| Jul 8, 26 | UBS | MAINTAINED | Buy | Buy |
| Jul 7, 26 | Barclays | INITIATED | Overweight | Overweight |
| Jun 23, 26 | Citigroup | UPGRADE | Neutral | Buy |
| Jun 18, 26 | Scotiabank | MAINTAINED | Sector Outperform | Sector Outperform |
Dividends & splits
Forward rate$1.00 / yr
Forward yield1.98%
5-year avg yield—
Payout ratio149.25%
Ex-dividend dateSep 30, 2026
Next pay dateOct 16, 2026
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-18
Corporate Changes & Voting Matters
8-K · 2026-09-14
Corporate Changes & Voting Matters
8-K · 2026-09-02
Corporate Changes & Voting Matters
8-K · 2026-09-01
Corporate Changes & Voting Matters
8-K · 2026-08-24
Corporate Changes & Voting Matters
8-K · 2026-08-12
Periodic Financial Reports
10-Q · 2026-08-07
Corporate Changes & Voting Matters
8-K · 2026-08-06
Headlines
Here's Why American Healthcare REIT (AHR) is Poised for a Turnaround After Losing 7.8% in 4 Weeks
Zacks · 1d ago
Coca Cola Stock And 2 Defensive Dividend Names Investors Are Watching
Simply Wall St. · 2d ago
Are Finance Stocks Lagging American Healthcare REIT, Inc. (AHR) This Year?
Zacks · 5d ago
American Healthcare REIT Announces Dates for Third Quarter 2026 Earnings Release and Conference Call
Business Wire · 6d ago
Zacks Industry Outlook Highlights American Healthcare REIT, Terreno Realty and RLJ Lodging Trust
Zacks · 14d ago
3 Equity REIT Stocks Worth Betting on Despite Industry Headwinds
Zacks · 15d ago
3 Defensive Stocks Investors Turn To When Rate Uncertainty Keeps Rising
Simply Wall St. · 16d ago
This Fund Exits American Healthcare REIT (AHR) Despite Bullish Outlook
Insider Monkey · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.